Back to MRKView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Malignant Neoplasms of Male Genital Organs
View Full LandscapeDrug Information
Target Indication
Malignant Neoplasms of Male Genital Organs
Clinical Trial
NCT02740127Last updated: 9/11/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Simvastatin 20 mg dailyPhase 3
Cardiovascular Disease
9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)Phase 3
HPV Positive Oropharyngeal Squamous Cell Carcinoma
0.9% sodium chloride (NaCl)Phase 3
Anesthesia
INFANRIX™ hexaPhase 3
Bacterial Infections
Letermovir 480 mg once dailyPhase 3
Kidney Transplant; Complications
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts